News

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels. As an ...
The State Bank of India (SBI) has released the admit cards for the SBI PO Mains 2025 exam, scheduled for May 5. Eligible candidates can download their call letters from the official website ...
Books and Authors Capsule for SBI PO Mains 2025 Moreover, for candidates targeting SBI PO Mains 2025, the Books & Authors section is another scoring area under the General Awareness section. Keeping ...
A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists—widely used in blockbuster ...
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, have recently gained attention for their effectiveness in managing weight gain, high blood sugar, ...
The results of a recent national study conducted by the Arkansas Agricultural Experiment Station found that these weight loss drugs — known as Glucagon-like peptide-1 agonists or GLP-1s — lead ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), currently licensed for the treatment of type 2 diabetes mellitus and obesity, offer a novel, multilayered mechanism for intervention in ...
TET2 works with HNF4α to activate the FBP1 gene upon glucagon stimulation, while metformin disrupts TET2-HNF4α interaction, lowering FBP1 levels and improving glucose homeostasis. The results are ...
This study presents a valuable finding on the role of cholesterol-binding site on GLP-1 receptors and functionally characterizes the impact of this mutation on receptor behavior in the membrane and ...
The State Bank of India has announced the SBI PO Prelims Result 2025, bringing a wave of excitement for thousands of candidates nationwide. Aspirants who appeared in the preliminary examination can ...
Drucker and three co-winners made discoveries about glucagon-like peptide-1 in their labs. The other recipient of the award, Lotte Bjerre Knudsen, who works for Novo Nordisk, led the way in ...